Internal Medicine, Hematology & Oncology · Cleveland, OH
NPI
1790955623
Since 2008
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
9500 Euclid Ave, R35
Cleveland, OH, 44195
Phone (216) 444-2451
Groups this clinician bills Medicare through
Medicare paid, 2024
$17K
266 services
Medicare patients, 2024
112
Average age 70
Drug cost, 2024
$2.5M
284 prescriptions
Company payments, 2025
$50K
From 8 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Dale R Shepard was code 99214 (office e&m - established), 113 times for 56 patients. In total Dale R Shepard billed 266 services in 12 codes, and Medicare paid $17K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2009-05-27.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Facility | 113 | 56 | $68.77 | $7,771 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 37 | 28 | $12.49 | $462 |
| 99215 Office E&M - Established | Facility | 24 | 17 | $108.97 | $2,615 |
| 99213 Office E&M - Established | Facility | 21 | 18 | $42.80 | $899 |
| 99213 Office E&M - Established | Office | 19 | 15 | $66.63 | $1,266 |
| 99204 Office E&M - New | Facility | 13 | 13 | $100.94 | $1,312 |
By year: 2022 $24K for 294 services; 2023 $17K for 237 services; 2024 $17K for 266 services.
Medicare prescription drug claims, 2024
In 2024, the drug Dale R Shepard prescribed most often to Medicare patients was Imatinib Mesylate, with 40 prescriptions and refills. In total Dale R Shepard wrote 284 Medicare prescriptions that cost $2.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Imatinib Mesylate Generic | 40 | 40 | Under 11 | $57K |
| Ibrance Palbociclib | 30 | 30 | Under 11 | $461K |
| Pazopanib Hcl Generic | 25 | 25 | Under 11 | $157K |
| Qinlock Ripretinib | 17 | 17 | Under 11 | $702K |
| Ogsiveo Nirogacestat Hydrobromide | 17 | 17 | Under 11 | $489K |
| Ondansetron Hcl Generic | 12 | 12 | Under 11 | $167 |
Brand drugs: 94 claims; generic drugs: 190 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Dale R Shepard $50K ($50K in general payments such as food, travel and fees) from 8 companies. The largest payer was SpringWorks Therapeutics, Inc. with $34K.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.